Frontiers | Research progress in inducing immunogenic cell death of tumor cells
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
Cancers | Free Full-Text | Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
Cells | Free Full-Text | Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer | Cell Death & Disease
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Frontiers | Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Cancer immunology - Wikipedia
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma - ScienceDirect
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Immune-Cell-Derived Exosomes for Cancer Therapy | Molecular Pharmaceutics
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer | Scientific Reports
Immune-checkpoint inhibitors: long-term implications of toxicity | Nature Reviews Clinical Oncology
Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets
What Are Immune Checkpoints?
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Nanoparticle-Based Immunotherapy for Cancer | ACS Nano
